The Food and Drug Administration gave MSN clearance for the generic version of Entresto in July. Novartis sued MSN and other companies looking to launch Entresto generics in Delaware federal court ...
(Reuters) - Novartis failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' blockbuster heart drug Entresto. The U.S. Court of Appeals for ...
The U.S. Court of Appeals has reportedly ruled against Novartis (NYSE:NVS) in its bid to prevent the U.S. launch of a generic version of its blockbuster heart failure drug Entresto. MSN’s ...
(Reuters) - Novartis failed to convince a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' blockbuster heart drug Entresto. The U.S. Court of Appeals for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results